| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.02 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.02 |